84 related articles for article (PubMed ID: 18695456)
1. Health care expenditures in ulcerative colitis: the perspective of a self-insured employer.
Hillson E; Dybicz S; Waters HC; Stuart B; Schaneman J; Dabbous O; Erwin WG; Kersh A; Broussard D
J Occup Environ Med; 2008 Aug; 50(8):969-77. PubMed ID: 18695456
[TBL] [Abstract][Full Text] [Related]
2. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.
Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J
J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698
[TBL] [Abstract][Full Text] [Related]
3. Long-term direct and indirect costs of ulcerative colitis in a privately-insured United States population.
Pilon D; Ding Z; Muser E; Obando C; Voelker J; Manceur AM; Kinkead F; Lafeuille MH; Lefebvre P
Curr Med Res Opin; 2020 Aug; 36(8):1285-1294. PubMed ID: 32427006
[No Abstract] [Full Text] [Related]
4. The direct and indirect cost burden of Crohn's disease and ulcerative colitis.
Gibson TB; Ng E; Ozminkowski RJ; Wang S; Burton WN; Goetzel RZ; Maclean R
J Occup Environ Med; 2008 Nov; 50(11):1261-72. PubMed ID: 19001952
[TBL] [Abstract][Full Text] [Related]
5. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
6. Medical resource utilization and associated costs in patients with ulcerative colitis in the UK: a chart review analysis.
Bodger K; Yen L; Szende A; Sharma G; Chen YJ; McDermott J; Hodgkins P
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):213-21. PubMed ID: 24145865
[TBL] [Abstract][Full Text] [Related]
7. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
9. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
10. Health care resource utilization and medical costs of spinal cord injury with neuropathic pain in a commercially insured population in the United States.
Margolis JM; Juneau P; Sadosky A; Cappelleri JC; Bryce TN; Nieshoff EC
Arch Phys Med Rehabil; 2014 Dec; 95(12):2279-87. PubMed ID: 25159715
[TBL] [Abstract][Full Text] [Related]
11. Surgical and nonsurgical hospitalization rates and charges for patients with ulcerative colitis in Italy: a 10-year cohort study.
Kohn A; Fano V; Monterubbianesi R; Davoli M; Marrollo M; Stasi E; Perucci C; Prantera C
Dig Liver Dis; 2012 May; 44(5):369-74. PubMed ID: 22197692
[TBL] [Abstract][Full Text] [Related]
12. Direct and indirect costs associated with Dupuytren's contracture.
Macaulay D; Ivanova J; Birnbaum H; Sorg R; Skodny P
J Med Econ; 2012; 15(4):664-71. PubMed ID: 22369346
[TBL] [Abstract][Full Text] [Related]
13. The economic consequences of irritable bowel syndrome: a US employer perspective.
Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ
Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202
[TBL] [Abstract][Full Text] [Related]
14. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
[TBL] [Abstract][Full Text] [Related]
15. Burden of venous leg ulcers in the United States.
Rice JB; Desai U; Cummings AK; Birnbaum HG; Skornicki M; Parsons N
J Med Econ; 2014 May; 17(5):347-56. PubMed ID: 24625244
[TBL] [Abstract][Full Text] [Related]
16. Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States.
Fu AZ; Jhaveri M
J Med Econ; 2012; 15(4):688-94. PubMed ID: 22397589
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States.
Kappelman MD; Rifas-Shiman SL; Kleinman K; Ollendorf D; Bousvaros A; Grand RJ; Finkelstein JA
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1424-9. PubMed ID: 17904915
[TBL] [Abstract][Full Text] [Related]
18. Payer status and access to laparoscopic subtotal colectomy for ulcerative colitis.
Greenstein AJ; Romanoff AM; Moskowitz AJ; Sosunov EA; Khaitov S; Egorova NN
Dis Colon Rectum; 2013 Sep; 56(9):1062-7. PubMed ID: 23929015
[TBL] [Abstract][Full Text] [Related]
19. Direct cost burden among insured US employees with migraine.
Hawkins K; Wang S; Rupnow M
Headache; 2008 Apr; 48(4):553-63. PubMed ID: 18070057
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiology and clinical characteristics of ulcerative colitis in north-eastern Mexico].
Bosques-Padilla FJ; Sandoval-García ER; Martínez-Vázquez MA; Garza-González E; Maldonado-Garza HJ
Rev Gastroenterol Mex; 2011; 76(1):34-8. PubMed ID: 21592901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
